Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth hormone for poor ovarian response in infertility treatment
IRCT20201003048912N2Phase 3Completed
- Sponsor
- Avicenna Infertility Clinic
- Start
- Jun 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of somatropin in female infertility (2 arms), sponsored by Avicenna Infertility Clinic. Primary endpoint: Clinical pregnancy. Started Jun 2020; status: completed.
02
Drugs
somatropin
03
Conditions
female infertility
Beyond the preview
Go deeper on IRCT20201003048912N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201003048912N2.